|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Autistic Disorder | |||||
| 2 | More general conditions related to this trial | ||||
| Child Development Disorders, Pervasive | |||||
| Mental Disorders | |||||
| Mental Disorders Diagnosed in Childhood | |||||
| 3 | Interventions listed in this trial | ||||
| Aripiprazole | |||||
| Placebo | |||||
| D-cycloserine | |||||
| fMRI | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Cycloserine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Anti-Infective Agents, Urinary | |||||
| Antibiotics, Antitubercular | |||||
| Antimetabolites | |||||
| Antipsychotic Agents | |||||
| Antitubercular Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Renal Agents | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||